Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
sergio.valente@uniroma1.it
Sergio Valente
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
sergio.valente@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2024
SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process
JOURNAL OF MEDICINAL CHEMISTRY
2024
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
2024
Theileria parasites sequester host eIF5A to escape elimination by host-mediated autophagy
NATURE COMMUNICATIONS
2024
Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem Cells
CHEMMEDCHEM
2024
Heterocycles-Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years
CHEMMEDCHEM
2024
Pharmacological Activation of SIRT3 Modulates the Response of Cancer Cells to Acidic pH
PHARMACEUTICALS
2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks
CELL DEATH DISCOVERY
2024
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey
JOURNAL OF MEDICINAL CHEMISTRY
2023
GreenMedChem- the challenge in the next decade toward eco-friendly compounds and processes in drug design
GREEN CHEMISTRY
2023
Role of SIRT3 in Microgravity Response: A New Player in Muscle Tissue Recovery
CELLS
2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells
JOURNAL OF MEDICINAL CHEMISTRY
2023
Histone deacetylase 10: A polyamine deacetylase from the crystal structure to the first inhibitors
CURRENT OPINION IN STRUCTURAL BIOLOGY
2023
SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROS
ANTIOXIDANTS
2023
Targeting ROS production through inhibition of NADPH oxidases
NATURE CHEMICAL BIOLOGY
2023
Hydroxamate-based compounds are potent inhibitors of Toxoplasma gondii HDAC biological activity
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
2023
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
2023
Inhibition of PKCθ Improves Dystrophic Heart Phenotype and Function in a Novel Model of DMD Cardiomyopathy
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy
JOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLE
2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
2022
1
2
3
4
5
seguente ›
ultima »
Progetti di Ricerca
Design and biological evaluation of novel epigenetic dual-targeting modulators to fight cancer
Laboratori di ricerca
LABORATORIO 256
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma